Atlantic Sapphire (OTC:AASZF) Stock, Quote.Headers.trade-ideas

Atlantic Sapphire ASA is engaged in fish farming activities locally to transform protein production globally. The group owns and operates land-based Atlantic salmon farms in Denmark and Homestead in the United States. Its brand portfolio includes Bluehouse Salmon and Sapphire salmon. Its geographical segments are the United States, Denmark, the Netherlands, and Other countries.

Fish As A Food Of The Future - This Company’s Low Cost Solution Is Ready

Penny Stocks

Markets

ATLANTIC SAPPHIRE AS by Atlantic Sapphire AS

AASZF

BSFC

NCRA

Read a recent profile of Nocera Inc. here

Fish have become an increasingly popular food with over 3 billion people relying on it as a source of protein. 

Fish As A Food Of The Future - This Company&#39;s Low Cost Solution Is Ready

Ringing In The Change For A New Era Of Fishing

Movers & Shakers

General

Read a recent profile of Nocera Inc. here

Nocera Inc. CEO Jeff Cheng rang the Nasdaq Stock Exchange closing bell Sept. 29 as part of the celebratory recognition of the company’s official NASDAQ listing. 

Amid Rising Inflation And Concerns Of Overfishing, Nocera Is Making Fishing Sustainable And Affordable 

Learn More about Nocera Inc. by gaining access to the latest research report

Amid Rising Inflation And Concerns Of Overfishing, Nocera Is Making Fishing Sustainable And Affordable

ATLANTIC SAPPHIRE AS by Atlantic Sapphire ASA

Atlantic Sapphire ASA

News

Legal

Albertsons Sues Kroger For Breach Of Merger Agreement, Citing Failure To Secure Regulatory Approval And Ignoring Antitrust Concerns; Seeks Billions In Damages Plus $600M Termination Fee For Harm To Business, Consumers, And Shareholders

Wolfe Research analyst Brad Hewitt initiates coverage on ITT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITT#NYSE">ITT</a>) with a Peer Perform rating.

Initiation

Analyst Ratings

Wolfe Research Initiates Coverage On ITT with Peer Perform Rating

<ul>
<li>Annual identical sales growth in the range of 1.8% to 2.2%.</li>
<li>Annual adjusted EBITDA in the range of $3.90 to $3.98 billion.</li>
<li>Annual adjusted net income per Class A common share ("Adjusted EPS") in the range of $2.20 to $2.30 per share.</li>
<li>Annual income tax rate of approximately 23%.</li>
<li>Annual capital expenditures in the range of $1.8 to $1.9 billion.</li>
</ul>

Guidance

Albertsons Sees FY24 Adj. EPS $2.20-$2.30 Vs $2.26 Est.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Truist Securities analyst Jake Bartlett downgraded Dave &amp; Buster&#8217;s Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>) from Buy to Hold and lowered the price target from $56 to $36. Dave &amp; Buster&#8217;s shares closed at $36.80 on Tuesday. <a href="https://www.benzinga.com/quote/PLAY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan analyst Pinjalim Bora downgraded the rating for C3.ai, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) from Neutral to Underweight and announced a $28 price target. C3.ai shares closed at $41.73 on Tuesday. <a href="https://www.benzinga.com/quote/AI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Matthew Bouley downgraded D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) from Overweight to Equal-Weight and lowered the price target from $192 to $170. D.R. Horton shares closed at $157.00 on Tuesday. See how other analysts view this stock.</li>
<li>Citigroup analyst Patrick Donnelly downgraded the rating for Illumina, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) from Buy to Neutral and lowered the price target from $190 to $165. Illumina shares closed at $148.53 on Tuesday. <a href="https://www.benzinga.com/quote/ILMN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Elyse Greenspan downgraded the rating for The Travelers Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) from Equal-Weight to Underweight and lowered the price target from $256 to $217. Travelers shares closed at $247.65 on Tuesday. <a href="https://www.benzinga.com/quote/TRV/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying DHI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="615" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11082723/image-91-1024x615.png" alt="" class="wp-image-687385" style="width:615px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11082723/image-91-1024x615.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11082723/image-91-300x180.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11082723/image-91-768x461.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/11082723/image-91.png 1118w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<a href="https://www.benzinga.com/news/earnings/24/12/42429181/macys-adobe-and-3-stocks-to-watch-heading-into-wednesday">Macy&#8217;s, Adobe And 3 Stocks To Watch Heading Into Wednesday</a>

Downgrades

Pre-Market Outlook

Trading Ideas

ILMN

PLAY

This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Dividends

Albertsons Increases Quarterly Dividend From $0.12 To $0.15

Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) reported its Q3 earnings results on Wednesday, December 11, 2024 at 08:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Vera Bradley missed estimated earnings by -550.0%, reporting an EPS of $-0.27 versus an estimate of $0.06.
Revenue was down $34.41 million from the same period last year.
<h3>Earnings History Overview</h3>
Last quarter the company missed on EPS by $0.03 which was followed by a 4.0% increase in the share price the next day.
Here's a look at Vera Bradley's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.16</td>
<td>0</td>
<td>0.14</td>
<td>0.09</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.13</td>
<td>-0.21</td>
<td>0.11</td>
<td>0.19</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>120.66M</td>
<td>90.39M</td>
<td>136.05M</td>
<td>123.09M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>110.82M</td>
<td>80.60M</td>
<td>133.26M</td>
<td>114.99M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Vera Bradley management provided guidance for FY 2025, expecting earnings between $-0.25 and $-0.25 per share.
 Listen to the earnings announcement yourself by <a href="">clicking here</a>. 
To track all earnings releases for Vera Bradley <a href="https://www.benzinga.com/quote/VRA/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Recap: Vera Bradley Q3 Earnings

MTCH

Match Group Updates Q4 2024 Outlook At Investor Day; Revenue Expected To Fall Below Prior Guidance Due To $15M FX Impact, Two-Thirds Attributable To Tinder; Full-Year Adjusted Operating Income Margin Still On Track At 36%

Buybacks

Albertsons Authorizes $2B Share Repurchase Program

AMPG

AmpliTech Group Announces Development And Deployment Of Its Low-Noise Cryogenic HEMT Amplifiers

Match Group Hosts Inaugural Investor Day, Announces $0.19 Quarterly Dividend And $1.5B Share Buyback Authorization; Plans To Return 100% Of Free Cash Flow To Shareholders Over Three Years Through Dividends And Repurchases

Albertsons Terminates Merger Agreement With Kroger

Biotech

ENLV

Enlivex Therapeutics Receives Regulatory Authorization From Israeli Ministry Of Health For Initiation Of Phase I Trial Evaluating Allocetra In Patients With TMJ Osteoarthritis

Refreshed Leadership To Accelerate Product Commercialization And Expand AI And Polymer Material Applications For Growth Opportunities

Management

LWLG

Lightwave Logic Appoints Yves LeMaitre As CEO And Thomas E. Zelibor As President

On Wednesday, Macy&#8217;s Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) reported third-quarter sales of $4.74 billion, beating the <a target="_blank" href="https://www.benzinga.com/trading-ideas/technicals/24/12/42422245/macys-q3-earnings-loom-can-bullish-momentum-break-200-day-resistance" rel="noreferrer noopener">consensus of $4.72 billion</a>.
Macy&#8217;s net sales decreased 2.4%, with comparable sales down 2.4% on an owned basis and down 1.3% on an owned-plus-licensed-<a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42432930/macys-inc-reports-third-quarter-2024-results" rel="noreferrer noopener">plus-marketplace basis</a>.
Sales growth at Macy&#8217;s First 50 locations, Bloomingdale&#8217;s, and Bluemercury was offset primarily by weakness in Macy&#8217;s non-First 50 locations, digital channels, and cold weather categories.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/42162655" rel="noreferrer noopener">Macy&#8217;s Delays Q3 Earnings Report Amid Investigation Over $154M Accounting Scandal; Stock Dips</a>
Macy&#8217;s go-forward business&nbsp;comparable sales were down 2.0% on an owned basis and down 0.9% on an owned-plus-licensed-plus-marketplace basis.
Bloomingdale&#8217;s net sales were up 1.4%, with comparable sales up 1.0% on an owned basis and up 3.2% on an owned-plus-licensed-plus-marketplace basis. Key drivers included strength in contemporary apparel, beauty, and digital.
Bluemercury net sales were up 3.2%, and comparable sales were up 3.3% on an owned basis.
&#8220;Our third quarter results reflect the positive momentum we are building through our Bold New Chapter strategy,&#8221; said Tony Spring, chairman and chief executive officer of Macy&#8217;s.
&#8220;We are encouraged by the consistent sales growth in our Macy&#8217;s First 50 locations and the strong performance of Bloomingdale&#8217;s and Bluemercury. Quarter-to-date, comparable sales continue to trend ahead of third-quarter levels across the portfolio.&#8221;
In November, the department store chain delayed its Q3 earnings release to allow for&nbsp;the completion of an <a target="_blank" href="https://www.benzinga.com/24/11/42162655/macy-falls-as-preliminary-q3-highlights-mixed-performance-and-154-million-expense-concealment" rel="noreferrer noopener">independent investigation</a>.
In its Q3 earnings release, the company said it identified that a single employee with responsibility for small package delivery expense accounting intentionally made erroneous accounting accrual entries to hide approximately $151 million of cumulative delivery expenses from the fourth quarter of 2021 through the third quarter of 2024
The retailer reported adjusted EPS of $0.04, down from $0.21 a year ago, beating the consensus of $0.03.
Guidance: Macy&#8217;s expects 2024 sales of&nbsp;$22.3 billion—$22.5 billion, compared to prior&nbsp;guidance&nbsp;of&nbsp;$22.1 billion—$22.4 billion&nbsp;and a consensus of&nbsp;$22.42 billion.
The company expects a 2024 comparable owned-plus-licensed-plus-marketplace sales change of Down ~1.0% to ~flat versus 2023 versus Down ~2.0% to down ~0.5% expected earlier.
Macy&#8217;s expects 2024 adjusted EPS of&nbsp;$2.25-$2.50&nbsp;compared to prior&nbsp;guidance&nbsp;of&nbsp;$2.34-$2.69&nbsp;and a consensus of&nbsp;$2.73, including accounting error.
Price Action: At last check on Wednesday, M stock was down 10.3% at $14.99 during the premarket session.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42177026" target="_blank" rel="noreferrer noopener">Peacock Pays Up: Macy&#8217;s Thanksgiving Parade Costs Set To Balloon For Content-Hungry NBC</a></li>
</ul>
Image via Shutterstock

Movers

Macy's Lowers Annual Profit Forecast Amid Accounting Misstep, Stock Tumbles

Wells Fargo analyst Larry Biegelsen downgrades RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) from Overweight to Equal-Weight and lowers the price target from $56 to $42.

Price Target

RXST

Wells Fargo Downgrades RxSight to Equal-Weight, Lowers Price Target to $42

Twice daily (BID) dosing regimen expected to maximize clinical benefit for patients by optimizing the activity of Aprea's experimental drug, ATRN-119, over a 24-hour daily cycle
New regimen potentially optimizes clinical outcomes and strengthens the clinical path forward
ATRN-119 is the first macrocyclic ATR inhibitor to enter clinical trials

APRE

Aprea Therapeutics Announces Twice Daily Dosing Of Patients On ABOYA-119 Clinical Trial Of ATRN-119

WIIM

SPWH

Sportsman's Warehouse shares are trading higher after B. Riley Securities upgraded the stock from Neutral to Buy and raised its price target from $2 to $4.

Truist Securities analyst Anthony Hau maintains DigitalBridge Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBRG#NYSE">DBRG</a>) with a Buy and lowers the price target from $17 to $15.

DBRG

Truist Securities Maintains Buy on DigitalBridge Gr, Lowers Price Target to $15

In the current market session, Trimble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMB#NASDAQ">TRMB</a>) stock price is at $74.00, after a 0.16% drop. However, over the past month, the company's stock spiked by 2.08%, and in the past year, by 43.14%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1733923840_0.png" alt="Past Year Chart" />

<h3>Evaluating Trimble P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 44.41 in the Electronic Equipment, Instruments &amp; Components industry, Trimble Inc. has a lower P/E ratio of 12.39. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1733923840_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

TRMB

P/E Ratio Insights for Trimble

SCPH

ScPharmaceuticals shares are trading lower after the company disclosed observed variability during shelf-life testing in one lot of its SCP-111 combination product. This may result in the submission occurring later in 2025.

Atlantic Sapphire (AASZF) has released an update. Atlantic Sapphire ASA has announced the completion of its rights issue, securing up to USD 64 mil...

Atlantic Sapphire Completes Major Funding Round

Atlantic Sapphire (AASZF) has released an update. Atlantic Sapphire ASA concluded its Rights Issue, resulting in the allocation of 6,417,000,001 ne...

Atlantic Sapphire Completes Rights Issue and Expansion Funding

Atlantic Sapphire (AASZF) has released an update. Atlantic Sapphire ASA announced the completion of a significant rights issue, resulting in the is...

Atlantic Sapphire Expands Share Capital and Warrants

Atlantic Sapphire (AASZF) has released an update. Condire Management, LP has significantly increased its stake in Atlantic Sapphire ASA, crossing t...

Condire Management Amplifies Stake in Atlantic Sapphire

Atlantic Sapphire (AASZF) has released an update. Nokomis Capital, LLC has acquired a significant stake in Atlantic Sapphire ASA through a rights o...

Nokomis Capital Ups Stake in Atlantic Sapphire

Atlantic Sapphire (AASZF) has released an update. Atlantic Sapphire ASA is making significant strides with its recent rights issue, resulting in a ...

Atlantic Sapphire Expands with Major Rights Issue

Atlantic Sapphire (AASZF) has released an update. Atlantic Sapphire ASA has announced a partially underwritten rights issue aiming to raise up to U...

Atlantic Sapphire Launches Major Rights Issue for Expansion

Atlantic Sapphire (AASZF) has released an update. Atlantic Sapphire ASA announces a significant capital increase through the issuance of over 641 m...

Atlantic Sapphire Expands Share Capital for Growth

Atlantic Sapphire (AASZF) has released an update. Atlantic Sapphire ASA has increased its share capital by NOK 32.08 million through the issuance o...

Atlantic Sapphire Expands Capital for Growth

Atlantic Sapphire (AASZF) has released an update. Atlantic Sapphire has revamped its share option scheme, granting up to 369.8 million share option...

Comments

Atlantic Sapphire

Atlantic Sapphire (AASZF) Forecast

Atlantic Sapphire (OTC:AASZF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga